BAFNAPH / NSE / Biotechnology & Drugs
Bafna Pharmaceuticals
1Y Price Trend
Key Information
Recommendations
Target High234.15
Target Low77.01
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk61.83
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent Markets Mojo
Above All Moving Averages and Now at Upper Circuit: Bafna Pharmaceuticals Ltd Gains 5.0% in a Single Session Markets Mojo
Bafna Pharmaceuticals Ltd Valuation Shifts Signal Price Attractiveness Challenges Markets Mojo
Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent Markets Mojo
Bafna Pharmaceuticals FY26 net profit rises to ₹1,109.98 lakh scanx.trade
Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5.09% Gain — Buyers Queue, Sellers Absent Markets Mojo
Bafna Pharmaceuticals standalone net profit rises 109.92% in the March 2026 quarter Business Standard
BAFNAPH: FY26 net profit more than doubled year-over-year, with strong revenue growth and clean audit TradingView
Stock FAQs
What is the symbol and ISIN of Bafna Pharmaceuticals?
Bafna Pharmaceuticals has the symbol BAFNAPH and ISIN - INE878I01022.
What is the current price of Bafna Pharmaceuticals?
Bafna Pharmaceuticals is currently trading at INR 225.88.
What are the year high and year low of Bafna Pharmaceuticals?
Bafna Pharmaceuticals has a year high of INR 234.15 and a year low of INR 77.01.
What is the market capitalization of Bafna Pharmaceuticals?
Bafna Pharmaceuticals has a market capitalization of INR 541.85 crore.
What is the P/E ratio of Bafna Pharmaceuticals?
Bafna Pharmaceuticals has a P/E ratio of 23.03.
What is the dividend yield of Bafna Pharmaceuticals?
Bafna Pharmaceuticals has a dividend yield of 0.00%.
How is the financial performance of Bafna Pharmaceuticals based on revenue, net income, and EPS?
Bafna Pharmaceuticals has revenue of INR 1,506.17 crore, net income of INR 111.00 crore, and EPS of INR 4.69.
What is the book value of Bafna Pharmaceuticals?
Bafna Pharmaceuticals has a book value of INR 40.64.
What is the debt-to-equity ratio of Bafna Pharmaceuticals?
Bafna Pharmaceuticals has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Bafna Pharmaceuticals?
Bafna Pharmaceuticals has a price-to-book ratio of 5.56 and a price-to-sales ratio of 0.36.
© SharekeyX | Rusaka Technologies 2024-2026